News
Latest News
We are excited to announce NewYorkBIO’s new Incubator & Accelerator Membership tiers, created to empower…
In 2025, NewYorkBIO launched New York Bio Connect, a first-of-its-kind resource hub. Designed for…
The award celebrates innovation, economic impact, and leadership in New York City’s thriving life sciences…
New York’s leading life science advocacy association and economic development organizations develop resource…
Statement on Behalf of Jennifer Hawks Bland, CEO of NewYorkBIO
Statement on behalf of Jennifer Hawks Bland, CEO of NewYorkBIO on Most Favored Nation Executive Order
New York, NY (April 23, 2025) – Mid Atlantic Bio Angels Group (MABA) and NewYorkBIO announced today a…
StatNews 04/16/2026
Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting ...
04/16/2026
Another Elevidys trial, FDA reconsiders peptides, and other biotech news from The Readout
04/16/2026
Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it ...
04/16/2026
How a rare disease drugmaker won FDA approval after a clinical trial disappointed.
04/15/2026
Revolution Medicines $2B fundraise, Structure's new hire hints at acquisition efforts, and more ...
04/15/2026
Beeline Medicine is focused on development of five inflammatory and immune disorder drugs, starting ...
04/14/2026
Ben Sasse on enrolling in Rev Med's drug trial, more ADC investment, and other biotech news from ...
04/14/2026
Rare disease clinical trials, policy discussions, and advocacy initiatives often leave adults ...
04/14/2026
Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but ...